Abstract:Objective: To evaluate a mouse model of chronic obstructive pulmonary disease (COPD) induced by intraperitoneal injections of cigarette smoke extract (CSE), and to study the potential mechanisms. Methods: Mice were injected intraperitoneally with CSE at different time points to establish a mouse model of COPD. Mouse lung mechanics parameters were measured, and the total numbers and differentials of cells in bronchoalveolar lavage fluid (BALF) were counted. Pathological changes of lung tissue were observed and mean linear intercept (MLI) and alveolar destructive index (DI) were measured. The expressions of matrix metalloproteinases-12(MMP12), neutrophil elastase (NE),tissue inhibitor of metalloproteinase-1(TIMP1), pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), Th1 cytokines (IFN-γ), Th2 cytokines (IL-5, IL-13) and the neutrophil chemokine KC were determined in the lungs of all mice. Results: Significant increase of total lung capacity(TLC) [(0.73 ± 0.02), (0.83 ± 0.04), (0.97 ± 0.02)ml] was found in the CSE group as compared with the PBS control group [(0.65 ± 0.01), (0.67 ± 0.02), (0.71 ± 0.04)ml, t= 4.109, 3.666, 5.994, P<0.01] at day 21, 41, 61. Lung compliance was higher in the CSE group [(0.041 ± 0.002) ml/cmH2O (1 cmH₂O= 0.098 kPa), (0.039 ± 0.001) ml/cmH₂O] than the PBS control group [(0.030 ± 0.001) ml/cmH₂O, (0.032 ± 0.003) ml/cmH₂O, t= 4.788,2.508, P<0.05] at day 41,61, but airway resistance in the lungs (R) was lower in the CSE group [(0.959 ± 0.016) cmH₂O·s·ml⁻¹, (0.976±0.020) cmH₂O·s·ml⁻¹] than the PBS control group [(1.043 ± 0.022) cmH₂O·s·ml(-1), (1.085±0.043) cmH₂O·s·ml⁻¹] (t= 2.928,2.321, P<0.05). The total numbers of BALF cells in the CSE group [(23.83 ± 2.63)×10⁴, (20.67±1.69)×10⁴, (18.67±1.56) × 10⁴] were increased compared with the PBS control group [(7.33 ± 0.61)×10⁴, (7.67 ± 0.76)×10⁴, (6.67 ± 0.88)×10⁴, t= 6.119,7.027,6.685,P<0.01] at day 21,41,61, predominantly with neutrophils and macrophages. Typical COPD pathological changes of lung tissue were evident, including Inflammatory cell infiltration in the lung parenchyma and increased mean linear intercept (MLI) in the CSE group [(48.0 ± 1.4), (56.1 ± 2.4), (59.3 ± 3.3)µm] as compared with the PBS control group [(40.5 ± 1.2), (43.7 ± 1.2), (43.5 ± 1.2)µm, t= 4.015,4.695,4.612, P<0.01] as well as increased alveolar destructive index (DI) in the CSE group [(15.2 ± 1.3)%, (22.4 ± 1.3)%, (23.8 ± 1.0)%] as compared with the PBS control group [(11.1 ± 0.9)%, (10.8 ± 1.0)%, (12.4 ± 0.7)%,t= 2.532, 7.225, 8.471, P < 0.05] at the 3 time points. The expressions of MMP12 and NE increased significantly in the CSE-treated mice. Pro-inflammatory cytokines (TNF-α, IL-1β, L-6), Th1 cytokine IFN-γ and KC all increased significantly in the CSE-treated mice as compared with the PBS-control mice. Conclusions: A mouse model of COPD was successfully established by repeated intraperitoneal injections of CSE in a shorter period of time. Local inflammation and proteinase/anti-proteinase imbalance as a result of CSE-induced immunological responses may be the underlying mechanisms.

HIV infection model of chronic obstructive pulmonary disease in mice

Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model.

Mitochondrial Iron Chelation Ameliorates Cigarette Smoke–induced Bronchitis and Emphysema in Mice

Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension

Micro-computed tomography imaging of cigarette smoke-exposed mice to model early chronic obstructive pulmonary disease (COPD)

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Establishment of a new cigarette smoke exposure device

Respiratory Syncytial Virus Infections Enhance Cigarette Smoke Induced COPD in Mice

2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis

[Evaluation of a mouse model of chronic obstructive pulmonary disease induced by intraperitoneal injections of cigarette smoke extract]

Animal models of cigarette smoke-induced chronic obstructive pulmonary disease

Tobacco smoke and morphine alter peripheral and CNS inflammation following HIV infection in a humanized mouse model

Establishment and Assessment of a Mouse Model of Cigarette Smoke-Induced Emphysema

Dynamic evolution of emphysema and airway remodeling in two mouse models of COPD

Cigarette Smoke with Poly I:C Challenges as an exacerbation model of acute lung inflammation

HIV-1 Tat Protein and Cigarette Smoke Mediated ADAM17 Upregulation Can Lead to Impaired Mucociliary Clearance

Imbalance of Th17/Treg Cells in Mice with Chronic Cigarette Smoke Exposure.

Establishment and Evaluation of a Rat Model of Sidestream Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.

A Novel Murine Chronic Obstructive Pulmonary Disease Model and the Pathogenic Role of MicroRNA-21

Development and validation of a mouse model of contemporary cannabis smoke exposure

Recent advances in pre-clinical mouse models of COPD